Role of Brf1 Interaction with ERα, and Significance of Its Overexpression, in Human Breast Cancer

Overview

Journal Mol Oncol

Specialties Molecular Biology
Oncology

Date 2017 Oct 4

PMID 28972307

Citations 25

Authors

Zeng Fang

Yunfeng Yi

Ganggang Shi

Songqi Li

Songlin Chen

Ying Lin

Zhi Li

Zhimin He

Wen Li

Shuping Zhong

Affiliations

Soon will be listed here.

Abstract

TFIIB-related factor 1 (Brf1) modulates the transcription of RNA Pol III genes (polymerase-dependent genes). Upregulation of Pol III genes enhances tRNA and 5S RNA production and increases the translational capacity of cells to promote cell transformation and tumor development. However, the significance of Brf1 overexpression in human breast cancer (HBC) remains to be investigated. Here, we investigate whether Brf1 expression is increased in the samples of HBC, and we explore its molecular mechanism and the significance of Brf1 expression in HBC. Two hundred and eighteen samples of HBC were collected to determine Brf1 expression by cytological and molecular biological approaches. We utilized colocalization, coimmunoprecipitation, and chromatin immunoprecipitation methods to explore the interaction of Brf1 with estrogen receptor alpha (ERα). We determined how Brf1 and ERα modulate Pol III genes. The results indicated that Brf1 is overexpressed in most cases of HBC, which is associated with an ER-positive status. The survival period of the cases with high Brf1 expression is significantly longer than those with low levels of Brf1 after hormone treatment. ERα mediates Brf1 expression. Brf1 and ERα are colocalized in the nucleus. These results indicate an interaction between Brf1 and ERα, which synergistically regulates the transcription of Pol III genes. Inhibition of ERα by its siRNA or tamoxifen reduces cellular levels of Brf1 and Pol III gene expression and decreases the rate of colony formation of breast cancer cells. Together, these studies demonstrate that Brf1 is a good biomarker for the diagnosis and prognosis of HBC. This interaction of Brf1 with ERα and Brf1 itself are potential therapeutic targets for this disease.

Citing Articles

Downregulation of Brf1 Induces Liver Failure and Inhibits Hepatocellular Carcinoma Progression by Promoting Apoptosis.

Xu Y, Yu C, Zhang H, Wang T, Liu Y, Wu L J Cancer. 2024; 15(17):5577-5593.

PMID: 39308682 PMC: 11414613. DOI: 10.7150/jca.97277.

MAF1 is a predictive biomarker in HER2 positive breast cancer.

Cabarcas-Petroski S, Olshefsky G, Schramm L PLoS One. 2023; 18(10):e0291549.

PMID: 37801436 PMC: 10558074. DOI: 10.1371/journal.pone.0291549.

Canine Somatic Mutations from Whole-Exome Sequencing of B-Cell Lymphomas in Six Canine Breeds-A Preliminary Study.

Kim S, Kim N, Kang H, Jang H, Lee A, Na K Animals (Basel). 2023; 13(18).

PMID: 37760246 PMC: 10525272. DOI: 10.3390/ani13182846.

Selection of tRNA Genes in Human Breast Tumours Varies Substantially between Individuals.

Butterfield S, Sizer R, Rand E, White R Cancers (Basel). 2023; 15(14).

PMID: 37509247 PMC: 10377016. DOI: 10.3390/cancers15143576.

BDP1 as a biomarker in serous ovarian cancer.

Cabarcas-Petroski S, Olshefsky G, Schramm L Cancer Med. 2022; 12(5):6401-6418.

PMID: 36305848 PMC: 10028122. DOI: 10.1002/cam4.5388.

References

Goodfellow S, Innes F, Derblay L, MacLellan W, Scott P, White R . Regulation of RNA polymerase III transcription during hypertrophic growth. EMBO J. 2006; 25(7):1522-33. PMC: 1440310. DOI: 10.1038/sj.emboj.7601040. View

Birch J, Clarke C, Campbell A, Campbell K, Mitchell L, Liko D . The initiator methionine tRNA drives cell migration and invasion leading to increased metastatic potential in melanoma. Biol Open. 2016; 5(10):1371-1379. PMC: 5087684. DOI: 10.1242/bio.019075. View

Zhong S, Machida K, Tsukamoto H, Johnson D . Alcohol induces RNA polymerase III-dependent transcription through c-Jun by co-regulating TATA-binding protein (TBP) and Brf1 expression. J Biol Chem. 2010; 286(4):2393-401. PMC: 3024733. DOI: 10.1074/jbc.M110.192955. View

Singletary K, Gapstur S . Alcohol and breast cancer: review of epidemiologic and experimental evidence and potential mechanisms. JAMA. 2001; 286(17):2143-51. DOI: 10.1001/jama.286.17.2143. View

Shi G, Zhong S . Alcohol-associated cancer and deregulation of Pol III genes. Gene. 2016; 612:25-28. PMC: 5374039. DOI: 10.1016/j.gene.2016.09.046. View

Macmahon B . Epidemiology and the causes of breast cancer. Int J Cancer. 2005; 118(10):2373-8. DOI: 10.1002/ijc.21404. View

Woiwode A, Johnson S, Zhong S, Zhang C, Roeder R, Teichmann M . PTEN represses RNA polymerase III-dependent transcription by targeting the TFIIIB complex. Mol Cell Biol. 2008; 28(12):4204-14. PMC: 2423115. DOI: 10.1128/MCB.01912-07. View

Zhong Q, Shi G, Zhang Y, Levy D, Zhong S . Elk1 and AP-1 sites in the TBP promoter mediate alcohol-induced deregulation of Pol III-dependent genes. Gene. 2013; 526(1):54-60. PMC: 3715583. DOI: 10.1016/j.gene.2013.02.004. View

Singletary K, Nelshoppen J, Wallig M . Enhancement by chronic ethanol intake of N-methyl-N-nitrosourea-induced rat mammary tumorigenesis. Carcinogenesis. 1995; 16(4):959-64. DOI: 10.1093/carcin/16.4.959. View

10.

Cogliano V, Baan R, Straif K, Grosse Y, Lauby-Secretan B, El Ghissassi F . Preventable exposures associated with human cancers. J Natl Cancer Inst. 2011; 103(24):1827-39. PMC: 3243677. DOI: 10.1093/jnci/djr483. View

11.

De Marchi T, Foekens J, Umar A, Martens J . Endocrine therapy resistance in estrogen receptor (ER)-positive breast cancer. Drug Discov Today. 2016; 21(7):1181-8. DOI: 10.1016/j.drudis.2016.05.012. View

12.

Zhong S, Johnson D . The JNKs differentially regulate RNA polymerase III transcription by coordinately modulating the expression of all TFIIIB subunits. Proc Natl Acad Sci U S A. 2009; 106(31):12682-7. PMC: 2722300. DOI: 10.1073/pnas.0904843106. View

13.

Toy W, Shen Y, Won H, Green B, Sakr R, Will M . ESR1 ligand-binding domain mutations in hormone-resistant breast cancer. Nat Genet. 2013; 45(12):1439-45. PMC: 3903423. DOI: 10.1038/ng.2822. View

14.

Demark-Wahnefried W, Goodwin P . To your health: how does the latest research on alcohol and breast cancer inform clinical practice?. J Clin Oncol. 2013; 31(16):1917-9. DOI: 10.1200/JCO.2013.49.0466. View

15.

Zhong Q, Shi G, Zhang Q, Lu L, Levy D, Zhong S . Tamoxifen represses alcohol-induced transcription of RNA polymerase III-dependent genes in breast cancer cells. Oncotarget. 2014; 5(23):12410-7. PMC: 4322994. DOI: 10.18632/oncotarget.2678. View

16.

Duncan J, Reeves J, Cooke T . BRCA1 and BRCA2 proteins: roles in health and disease. Mol Pathol. 1999; 51(5):237-47. PMC: 395646. DOI: 10.1136/mp.51.5.237. View

17.

Zhong S, Fromm J, Johnson D . TBP is differentially regulated by c-Jun N-terminal kinase 1 (JNK1) and JNK2 through Elk-1, controlling c-Jun expression and cell proliferation. Mol Cell Biol. 2006; 27(1):54-64. PMC: 1800663. DOI: 10.1128/MCB.01365-06. View

18.

Siegel R, Miller K, Jemal A . Cancer Statistics, 2017. CA Cancer J Clin. 2017; 67(1):7-30. DOI: 10.3322/caac.21387. View

19.

Zhong Q, Xi S, Liang J, Shi G, Huang Y, Zhang Y . The significance of Brf1 overexpression in human hepatocellular carcinoma. Oncotarget. 2015; 7(5):6243-54. PMC: 4868753. DOI: 10.18632/oncotarget.6668. View

20.

Babu R, Kumar M, Patil R, Devaraju K, Ramesh G, Sharma S . Effect of estrogen and tamoxifen on the expression pattern of AP-1 factors in MCF-7 cells: role of c-Jun, c-Fos, and Fra-1 in cell cycle regulation. Mol Cell Biochem. 2013; 380(1-2):143-51. DOI: 10.1007/s11010-013-1667-x. View